Cancer therapy developer G1 Therapeutics has gone public in an initial public offering that gave an exit to long-time investor MedImmune Ventures.
The reverse merger with Nasdaq-listed Mirna, which counts Pfizer and Baxter as backers, was agreed alongside the disclosure of a $42m series C round.
iRhythm Technologies, a developer of arrhythmia diagnostics technology spun out of Stanford University, has been awarded Exit of the Year by Global University Venturing.
Bruker has acquired Luxendo, a spinout of the European Molecular Biology Laboratory that closed an $8.4m series A round in January.
Yum China is set to purchase a majority stake in Daojia, an online food ordering platform that has raised some $75m from investors including JD.com.
The dark data processing technology developer, based on Stanford research, has been bought by Apple after raising about $20m from investors including In-Q-Tel.
The dark data processing technology developer has been bought by Apple after raising about $20m from investors including GV.
The machine learning-equipped online lender is exploring a flotation in the US that will allow Sunshine Insurance and Fosun to exit.
Mail.ru has acquired the remaining 90% stake in food delivery platform and portfolio company Zakazaka in a deal that valued the startup at $20m.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
